Tolerance to noninherited maternal antigens in mice and humans

Current Opinion in Organ Transplantation

Volumn 14, Issue 4, 2009, Pages 439-447

  Dutta, Partha ^a,b   Burlingham, William J ^a,c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c University of Wisconsin Health   (United States)

Author keywords

Microchimerism; Noninherited maternal antigens; T regulatory cells; Tolerance

Indexed keywords

ANTIGEN; NONINHERITED MATERNAL ANTIGEN; UNCLASSIFIED DRUG;

AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; FETOMATERNAL TRANSFUSION; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; MICROCHIMERISM; NONHUMAN; ORGAN TRANSPLANTATION; PREGNANCY; REGULATORY T LYMPHOCYTE; REVIEW; STEM CELL; TISSUE REGENERATION;

ANIMALS; CHIMERISM; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY, MATERNAL-FETAL; HUMANS; IMMUNE TOLERANCE; MICE; ORGAN TRANSPLANTATION; PREGNANCY; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 68849105728     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32832d6683     Document Type: Review

References (74)

1. Burlingham WJ, Goulmy E. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. Hum Immunol 2008; 69:728-731.
2. Hourmant M, Cesbron-Gautier A, Terasaki PI, et al. Frequency and clinical implications of development of donor-specific and nondonor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005; 16:2804-2812.
3. Lee PC, Terasaki PI, Takemoto SK, et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002; 74:1192-1194.
4. Gallon L, Watschinger B, Murphy B, et al. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression. Transplantation 1995; 59:612-616.
5. Carstens J, Andersen HK, Spencer E, Madsen M. Cytomegalovirus infection in renal transplant recipients. Transpl Infect Dis 2006; 8:203-212. (Pubitemid 44787859)
6. Lopez MM, Valenzuela JE, Alvarez FC, et al. Long-term problems related to immunosuppression. Transpl Immunol 2006; 17:31-35.
7. Penn I. Posttransplant malignancy: the role of immunosuppression. Drug Saf 2000; 23:101-113.
8. Owen RD, Wood HR, Foord AG, et al. Evidence for actively acquired tolerance to Rh antigens. Proc Natl Acad Sci U S A 1954; 40:420-424.
9. Claas FH, Gijbels Y, van der Velden-de Munck J, van Rood JJ. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science 1988; 241:1815-1817. (Pubitemid 18240887)
10. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science 1945; 102:400-401.
11. Billingham RE, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172:603-606.
12. Burlingham WJ, Grailer AP, Heisey DM, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998; 339:1657-1664.
13. van Rood JJ, Loberiza FR Jr, Zhang MJ, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling. Blood 2002; 99:1572-1577.
14. Ichinohe T, Uchiyama T, Shimazaki C, et al. Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood 2004; 104:3821-3828. (Pubitemid 39564463)
15. Zhang L, Miller RG. The correlation of prolonged survival of maternal skin grafts with the presence of naturally transferred maternal T cells. Transplantation 1993; 56:918-921. (Pubitemid 23321529)
16. Andrassy J, Kusaka S, Jankowska-Gan E, et al. Tolerance to noninherited maternal MHC antigens in mice. J Immunol 2003; 171:5554-5561. (Pubitemid 37432846)
17. Molitor-Dart ML, Andrassy J, Haynes LD, Burlingham WJ. Tolerance induction or sensitization in mice exposed to noninherited maternal antigens (NIMA). Am J Transplant 2008; 8:2307-2315. The article reports that exposure to NIMA not only induces tolerance but also sensitization depending on the breeding system.
18. Muller D, Chen M, Vikingsson A, et al. Oestrogen influences CD4+ T-lymphocyte activity in vivo and in vitro in beta 2-microglobulin-deficient mice. Immunology 1995; 86:162-167.
19. Matsuoka K, Ichinohe T, Hashimoto D, et al. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism. Blood 2006; 107:404-409. (Pubitemid 43053570)
20. Molitor-Dart ML, Andrassy J, Kwun J, et al. Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol 2007; 179:6749-6761.
21. Mold JE, Michaelsson J, Burt TD, et al. Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero. Science 2008; 322:1562-1565. The authors reported that exposure to maternal antigens in human fetus induced TR in the lymph node, which is TGF-b dependent.
22. Burlingham WJ. A lesson in tolerance: maternal instruction to fetal cells. N Engl J Med 2009; 360:1355-1357. This paper is a review of the study by Mold et al. and provides a new model for NIMA-induced tolerance.
23. Vernochet C, Caucheteux SM, Gendron MC, et al. Affinity-dependent alterations of mouse B cell development by noninherited maternal antigen. Biol Reprod 2005; 72:460-469. (Pubitemid 40129723)
24. Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006; 6:584-594.
25. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nat Rev Genet 2001; 2:538-548. (Pubitemid 33674027)
26. Lo YM, Lo ES, Watson N, et al. Two-way cell traffic between mother and fetus: biologic and clinical implications. Blood 1996; 88:4390-4395. (Pubitemid 26399188)
27. Rinkevich B. Human natural chimerism: an acquired character or a vestige of evolution? Hum Immunol 2001; 62:651-657.
28. Evans PC, Lambert N, Maloney S, et al. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999; 93:2033-2037. (Pubitemid 29128506)
29. Aractingi S, Berkane N, Bertheau P, et al. Fetal DNA in skin of polymorphic eruptions of pregnancy. Lancet 1998; 352:1898-1901. (Pubitemid 28561251)
30. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93:705-708.
31. Lo ES, Lo YM, Hjelm NM, Thilaganathan B. Transfer of nucleated maternal cells into fetal circulation during the second trimester of pregnancy. Br J Haematol 1998; 100:605-606. (Pubitemid 28270504)
32. Maloney S, Smith A, Furst DE, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104:41-47. (Pubitemid 29534343)
33. Socie G, Gluckman E, Carosella E, et al. Search for maternal cells in human umbilical cord blood by polymerase chain reaction amplification of two minisatellite sequences. Blood 1994; 83:340-344. (Pubitemid 24030556)
34. Scaradavou A, Carrier C, Mollen N, et al. Detection of maternal DNA in placental/umbilical cord blood by locus-specific amplification of the noninherited maternal HLA gene. Blood 1996; 88:1494-1500. (Pubitemid 26276828)
35. Petit T, Dommergues M, Socie G, et al. Detection of maternal cells in human fetal blood during the third trimester of pregnancy using allele-specific PCR amplification. Br J Haematol 1997; 98:767-771. (Pubitemid 27386562)
36. Hall JM, Lingenfelter P, Adams SL, et al. Detection of maternal cells in human umbilical cord blood using fluorescence in situ hybridization. Blood 1995; 86:2829-2832.
37. Loubiere LS, Lambert NC, Flinn LJ, et al. Maternal microchimerism in healthy adults in lymphocytes, monocyte/macrophages and NK cells. Lab Invest 2006; 86:1185-1192.
38. Lambert NC, Erickson TD, Yan Z, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum 2004; 50: 906-914. (Pubitemid 38326192)
39. Kaplan J, Land S. Influence of maternal-fetal histocompatibility and MHC zygosity on maternal microchimerism. J Immunol 2005; 174:7123-7128. (Pubitemid 40705678)
40. Zhou L, Yoshimura Y, Huang Y, et al. Two independent pathways of maternal cell transmission to offspring: through placenta during pregnancy and by breast-feeding after birth. Immunology 2000; 101:570-580. (Pubitemid 32001473)
41. Nelson JL, Gillespie KM, Lambert NC, et al. Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism. Proc Natl Acad Sci U S A 2007; 104:1637-1642.
42. Lambert NC, Evans PC, Hashizumi TL, et al. Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity. J Immunol 2000; 164:5545-5548.
43. Khosrotehrani K, Leduc M, Bachy V, et al. Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers. J Immunol 2008; 180:889-897. The article reports that fetal hematopoietic progenitor cells can differentiate into adult cells in the mother.
44. Cai J, Lee J, Jankowska-Gan E, et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J Exp Med 2004; 199:1017-1023. (Pubitemid 38481093)
45. Stevens AM HH, Kiefer MM, Rutledge JC, Nelson JL. Chimeric maternal cells with tissue-specific antigen expression and morphology are common in infant tissues. Pediatr Dev Pathol 2008. [Epub ahead of print] The article reports that maternal microchimeric cells express tissue-specific antigens indicating the presence of maternal pluripotent cells in the offspring.
46. Bianchi DW. Fetomaternal cell traffic, pregnancy-associated progenitor cells, and autoimmune disease. Best Pract Res Clin Obstet Gynaecol 2004; 18:959-975.
47. Chen CP, Lee MY, Huang JP, et al. Trafficking of multipotent mesenchymal stromal cells from maternal circulation through the placenta involves vascular endothelial growth factor receptor-1 and integrins. Stem Cells 2008; 26:550-561. The article supports the idea that pluripotent maternal stem cells can cross the placenta, take residence in different organs of the fetus, and differentiate into adult maternal cells.
48. Khosrotehrani K, Johnson KL, Cha DH, et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004; 292:75-80. (Pubitemid 38923796)
49. Starzl TE, Demetris AJ, Trucco M, et al. Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med 1993; 328:745-749. (Pubitemid 23082036)
50. Starzl TE, Demetris AJ, Trucco M, et al. Systemic chimerism in human female recipients of male livers. Lancet 1992; 340:876-877.
51. Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol Today 1996; 17:584-587; discussion 588. (Pubitemid 26423424)
52. Hamano K, Rawsthorne MA, Bushell AR, et al. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation 1996; 62:856-860. (Pubitemid 26332854)
53. Burlingham WJ, Grailer AP, Fechner JH Jr, et al. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995; 59:1147-1155.
54. Bonilla WV, Geuking MB, Aichele P, et al. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J Clin Invest 2006; 116:156-162. (Pubitemid 43121800)
55. Bemelman F, Honey K, Adams E, et al. Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol 1998; 160:2645-2648. (Pubitemid 28136714)
56. Gonnella PA, Kodali D, Weiner HL. Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice. J Immunol 2003; 170:2316-2322. (Pubitemid 36245617)
57. Marth T, Strober W, Kelsall BL. High dose oral tolerance in ovalbumin TCR-transgenic mice: systemic neutralization of IL-12 augments TGF-beta secretion and T cell apoptosis. J Immunol 1996; 157:2348-2357. (Pubitemid 126450444)
58. Molitor ML, Haynes LD, Jankowska-Gan E, et al. HLA class I noninherited maternal antigens in cord blood and breast milk. Hum Immunol 2004; 65:231-239. (Pubitemid 38369261)
59. Campbell DA Jr, Lorber MI, Sweeton JC, et al. Breast feeding and maternaldonor renal allografts. Possibly the original donor-specific transfusion. Transplantation 1984; 37:340-344.
60. Aoyama K, Koyama M, Matsuoka KI, et al. Improved outcome of allogeneic bone marrow transplantation due to breast-feeding-induced tolerance to maternal antigens. Blood 2009; 113:1829-1833. The article reports that both in-utero and oral exposures to the NIMA are important in NIMA-induced tolerance. Oral exposure to the NIMA can itself induce some degree of tolerance to NIMA.
61. Tsang JY, Tanriver Y, Jiang S, et al. Conferring indirect allospecificity on CD4+CD25+ Tregs by TCR gene transfer favors transplantation tolerance in mice. J Clin Invest 2008; 118:3619-3628. The article says TR having both indirect and direct allospecificity are very potent in inducing allograft tolerance. Similarly offspring TR that can be presented with antigens by both maternal APCs (direct presentation) and offspring APCs (indirect presentation) may be very potent in inducing NIMA tolerance.
62. R having indirect and direct allospecificity in allograft tolerance.
63. Herrera OB, Golshayan D, Tibbott R, et al. A novel pathway of alloantigen presentation by dendritic cells. J Immunol 2004; 173:4828-4837. (Pubitemid 39387763)
64. Daubeuf S, Puaux AL, Joly E, Hudrisier D. A simple trogocytosis-based method to detect, quantify, characterize and purify antigen-specific live lymphocytes by flow cytometry, via their capture of membrane fragments from antigen-presenting cells. Nat Protoc 2006; 1:2536-2542.
65. Harshyne LA, Watkins SC, Gambotto A, Barratt-Boyes SM. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001; 166:3717-3723. (Pubitemid 32224894)
66. Segura E, Guerin C, Hogg N, et al. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007; 179: 1489-1496.
67. Harshyne LA, Zimmer MI, Watkins SC, Barratt-Boyes SM. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J Immunol 2003; 170:2302-2309.
68. Hudrisier D, Aucher A, Puaux AL, et al. Capture of target cell membrane components via trogocytosis is triggered by a selected set of surface molecules on T or B cells. J Immunol 2007; 178:3637-3647. (Pubitemid 46417631)
69. Smyth LA, Afzali B, Tsang J, et al. Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am J Transplant 2007; 7:1442-1449. (Pubitemid 46776254)
70. Caumartin J, Lemaoult J, Carosella ED. Intercellular exchanges of membrane patches (trogocytosis) highlight the next level of immune plasticity. Transpl Immunol 2006; 17:20-22.
71. Caumartin J, Favier B, Daouya M, et al. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007; 26:1423-1433.
72. LeMaoult J, Caumartin J, Daouya M, et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007; 109:2040-2048. (Pubitemid 46348204)
73. van Halteren AGS, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, Burlingham WJ, Goulmy E. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood 2009. [Epub ahead of print]
74. ChanWF, Razavy H, Luo B, et al. Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras. J Immunol 2008; 180:5177-5186. The article reports that presence of unilineage microchimerism generates split tolerance resulting in allograft rejection, whereas multilineage microchimerism can induce tolerance.